Supporting You At Every Stage
Growing a tiny human can be exhausting, but your diabetes management doesn’t need to be!
The Dexcom G6 Continuous Glucose Monitoring (CGM) System helps people with diabetes† achieve better glucose management.1-7
The Australian Government offers access to subsidised CGM for Australians living with type 1 diabetes including women who are actively planning pregnancy, pregnant, or immediately post-pregnancy through the National Diabetes Services Scheme (NDSS) Initiative.
†This product is indicated for persons with diabetes mellitus age 2 years and older where SMBG is indicated.
What is Continuous Glucose Monitoring (CGM)?
CGM systems are diabetes management tools that measure glucose using a sensor inserted just under the skin that measures glucose levels 24 hours a day. It provides you with real-time glucose readings to your compatible smart device‡ or optional Dexcom Receiver but can also alert you when your levels rise too high or drop too low.
The Benefits of Dexcom CGM
Tight glycaemic management is never more important than when you are expecting. Always know your glucose levels, where they’re headed and how fast with just a quick glance at your smartphone or watch,‡ so you can take action sooner.
Zero Fingerpricking*
With Dexcom G6 you always know your glucose levels without fingerpricking*.
*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
Urgent Low Soon Alert
The Urgent Low Soon alert can warn you 20 minutes in advance of a serious hypo, so you can take action.
Share Data
Widen your support network by sharing readings and alerts with loved ones who can help you stay aware of impeding hyper and hypo events.§
Customisable Alerts
Dexcom G6’s customisable alerts can let you know if your glucose is going too high or too low.
Accurate Glucose Readings
Exceptional accuracy6 you can count on so that you can make confident treatment decisions.
Dexcom Clarity
You’ve got enough to think about without keeping a diabetes diary. Dexcom Clarity app keeps track of all your data and trends and can share them with your healthcare team.
Just found out you’re pregnant?
Congratulations! You've got this. It’s important to maintain tight glycaemic management during pregnancy but hormones can make glucose management a challenge. Pregnancy is challenging enough!
Speak to your Diabetes Healthcare Team about accessing the Dexcom G6 CGM system – NDSS funding for CGM is available to pregnant women with type 1 diabetes.
If you do not qualify for the NDSS subsidy you can visit our shop here
Download the leaflet below and talk to your Diabetes Healthcare Team about Dexcom CGM.
Take control before you conceive!
When you have type 1 diabetes, attaining tight glycaemic management of your glucose levels is important when trying to conceive.
Let Dexcom assist you in taking care of your diabetes management so you can get back to picking out names!
Purchase our trial kit and get all you need for up to 30 days of wear for just $95†! Don’t forget if you have type 1 diabetes and are activley trying ask your healthcare team about NDSS funding.
Ready to take the next step?
Speak to your Diabetes Healthcare Team
Dexcom G6 CGM is fully subsidised for pregnant women and women planning to become pregnant with type 1 diabetes. To explore subsidised CGM, we encourage you to reach out to your Diabetes Healthcare Team. Additionally, for more information, simply click the button below.
Not eligible for subsidy?
You can easily shop via AMSL Diabetes (a Dexcom company) our online store by clicking the button below!
Still have questions about Dexcom G6?
Speak to one of our product specialists.
ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on dexcom.com/en-AU/downloadsandguides before purchasing. Consult your healthcare professional to see if this product is right for you.
* If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions
‡ Smart devices sold separately. For a list of compatible devices, visit www.dexcom.com/compatibility§ Internet connectivity required for data sharing. Following requires the use of the Follow App. Followers should always confirm readings on the Dexcom G6 App or Receiver before making treatment decisions
‡ Smart devices sold separately. For a list of compatible devices, visit www.dexcom.com/compatibility§ Internet connectivity required for data sharing. Following requires the use of the Follow App. Followers should always confirm readings on the Dexcom G6 App or Receiver before making treatment decisions
1. American Diabetes Association Professional Practice Committee; 15 Diabetes Care. 2022;45(suppl 1):S232–S243.
2. ACOG Practice Bulletin No. 190. Obstet Gynecol. 2018;131(2):e49-e64.
3. Feig DS. Diabetes Care. 2022;45(11):2484-2491.
4. Beck RW, et al. JAMA. 2017;317(4):371-378.
5. Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
6. Castorino K, et al. Diabetes Technol Ther. 2020;22(12):943-947.
7. Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
2. ACOG Practice Bulletin No. 190. Obstet Gynecol. 2018;131(2):e49-e64.
3. Feig DS. Diabetes Care. 2022;45(11):2484-2491.
4. Beck RW, et al. JAMA. 2017;317(4):371-378.
5. Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
6. Castorino K, et al. Diabetes Technol Ther. 2020;22(12):943-947.
7. Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
MAT-2102